Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -162.47% | 81.31% | -111.49% | -11.41% | -46.04% |
| Total Depreciation and Amortization | 5.39% | 12.08% | -3.60% | 4.47% | 13.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 156.20% | -137.00% | 247.19% | 16.31% | 151.32% |
| Change in Net Operating Assets | -226.39% | -49.92% | 55.81% | 418.20% | 50.94% |
| Cash from Operations | -21.32% | -37.76% | -23.17% | 27.08% | -5.74% |
| Capital Expenditure | -27.08% | 58.55% | -40.86% | -200.86% | -13.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -27.08% | 58.55% | -40.86% | -200.86% | -13.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.29% | 60.06% | -198.33% | -5.26% | -16.33% |
| Issuance of Common Stock | -99.96% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 84.36% | -59,050.00% | -- | -- | 100.00% |
| Cash from Financing | -102.28% | 9,900.79% | -110.00% | -5.26% | -100.40% |
| Foreign Exchange rate Adjustments | -60.00% | 33.33% | 85.71% | 0.00% | -452.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.66% | 325.43% | -26.21% | 14.31% | -130.11% |